Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.235ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.235ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.235NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.65ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.65ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.65ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.65NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.45ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.45ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.45ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
B.45NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.165ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.165ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.165ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.165NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.258.12ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.258.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.12NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
V.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.525ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.525ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.525NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.480ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15159.2France
B.1.480ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.480ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.480NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.214ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.214ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.214ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.214NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.304ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.304ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.304ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.304NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.214.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.214.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.214.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.214.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.577ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.577ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.577ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.577NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.639ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.639ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.639ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.639NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
A.2.5.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
A.2.5.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.2.5.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used